Apipharma FDA Record
- Latest inspection OAI · Mar 28, 2025
- No warning letters matched by name
Apipharma has 2 FDA recalls, 2 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Apipharma" is on file.
- Latest recall
- D-0376-2025 · Class II · Apr 9, 2025
- Latest inspection
- Mar 28, 2025 · OAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 2 | Nov 15, 2026 | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 2 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Apipharma: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 1 | 0 | 2 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 1 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Apipharma as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Apipharma yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0376-2025 | Class II | Kapsin Ointment, Camphor 3.16% and Capsaicin 0.03%. Net Wt. 2 oz (60g) tubes, Manufactured by… | Apr 9, 2025 |
| D-0375-2025 | Class II | Hemopropin Ointment, Lanolin 17.76% and Petrolatum 71.2%, Net Wt. 0.7 oz (20g) tubes, Manufactured… | Apr 9, 2025 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Mar 28, 2025 | Nasice, Croatia | Drugs | Official Action Indicated (OAI) | 3010235999 |
| Sep 26, 2019 | Nasice, Croatia | Drugs | Voluntary Action Indicated (VAI) | 3010235999 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3010235999 | Nasice, Croatia | 2 | Mar 28, 2025 |
Apipharma and the FDA: common questions
Has Apipharma received an FDA warning letter?
No FDA warning letter addressed to the name "Apipharma" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Apipharma received an FDA Form 483?
FDA has not published a Form 483 for "Apipharma" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Apipharma?
The most recent FDA inspection on file ended Mar 28, 2025 at Nasice, Croatia and was classified OAI. FDA has 2 inspections of Apipharma on file, 1 of them classified OAI (official action indicated).
Has Apipharma had an FDA recall?
Yes. Apipharma has 2 FDA recalls on record. The most recent started Apr 9, 2025.
Need more than this page shows? Ask about Apipharma in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.